|
TCRX Tscan Therapeutics Inc 1783328 |
| Balance Sheet |
|
Current Assets
|
274,085,000 |
|
Assets
|
348,027,000 |
|
Current Liabilities
|
28,660,000 |
|
Liabilities
|
118,940,000 |
|
Equity
|
229,087,000 |
|
Shares Out
|
48,697,000 |
| Cash Flow Statement |
|
Operating Cash Flow
|
-83,410,000 |
|
Investing Cash Flow
|
-79,906,000 |
| Market Analysis |
Market Cap
|
295,594,134 |
|
Price
|
2.40 |
|
BVPS
|
4.70 |
|
PB
|
0.52 |
|
EPS
|
-1.05 |
|
PS
|
70.45 |
|
FCF
|
-163,316,000 |
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view TCRX documents filed with the SEC.
TCRX Filings
Clear
